Please use this identifier to cite or link to this item:
|Title:||Intrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole|
|Source:||Karim, S.M.M., Ratnam, S.S., Choo, H.T. (1974). Intrauterine administration of prostaglandin 15 (S) 15 methyl E2 methyl ester in the management of patients with a hydatidiform mole. J.OBSTET.GYNAEC.BRIT.CWLTH 81 (8) : 650-651. ScholarBank@NUS Repository.|
|Abstract:||Intrauterine administration of Prostaglandin 15 (S) 15 methyl E2 methyl ester was successfully used to evacuate the uterus in 20 patients with a hydatidiform mole. 15 patients aborted with a single intrauterine dose of 30 μg of the analogue and 5 were given a second dose 8 hr later. The interval between the first dose to expulsion of the hydatidiform mole ranged from 2 3/4 hr to 16 hr with a mean of 9 hr 4 min for the 20 patients.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 13, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.